levodopa has been researched along with bupropion in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Kruk, ZL; Millar, J; Stamford, JA | 1 |
| Becker, RE; Blitzer, RD | 1 |
| Kuhr, WG; May, LJ; Wightman, RM | 1 |
| Cooper, BR; Howard, JL; Soroko, FE | 1 |
| Mahowald, MW; Schenck, CH | 1 |
| Grabowski, J; Herin, DV; Rush, CR | 1 |
| Benincasa, D; Fanciulli, A; Pellicano, C; Pontieri, FE | 1 |
| Hansard, MJ; Jackson, MJ; Jenner, P; Rose, S; Smith, LA | 1 |
| Campos, FL; Carvalho, MM; Coimbra, B; Lima, R; Pêgo, JM; Rodrigues, AJ; Rodrigues, C; Salgado, AJ; Sousa, N | 1 |
1 review(s) available for levodopa and bupropion
| Article | Year |
|---|---|
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Topics: Animals; Behavior Therapy; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cognition; Dextroamphetamine; Humans; Levodopa; Methylphenidate; Modafinil; Substance-Related Disorders | 2010 |
10 other study(ies) available for levodopa and bupropion
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Dissociation of the actions of uptake blockers upon dopamine overflow and uptake in the rat nucleus accumbens: in vivo voltammetric data.
Topics: Animals; Benztropine; Bupropion; Cocaine; Dopamine; Electric Stimulation; Electrochemistry; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Nucleus Accumbens; Piperazines; Propiophenones; Rats; Rats, Inbred Strains; Septal Nuclei | 1989 |
Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Brain; Bromocriptine; Bupropion; Central Nervous System Stimulants; Cues; Generalization, Stimulus; Levodopa; Male; Nomifensine; Propiophenones; Rats; Receptors, Dopamine; Viloxazine | 1985 |
Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Benztropine; Bupropion; Caudate Nucleus; Dopamine; Electric Stimulation; Electrochemistry; Extracellular Space; Kinetics; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Rats; Rats, Inbred Strains | 1988 |
Animal models used in prediction of antidepressant effects in man.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depressive Disorder; Drug Evaluation, Preclinical; Drug Synergism; Helplessness, Learned; Humans; Levodopa; Mice; Models, Biological; Motor Activity; Propiophenones; Rats; Reserpine; Tetrabenazine | 1983 |
Combined bupropion-levodopa-trazodone therapy of sleep-related eating and sleep disruption in two adults with chemical dependency.
Topics: Adult; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Bupropion; Depressive Disorder, Major; Drug Therapy, Combination; Feeding and Eating Disorders; Female; Humans; Levodopa; Male; Substance-Related Disorders; Trazodone; Wakefulness | 2000 |
Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Bupropion; Compulsive Behavior; Dopamine Uptake Inhibitors; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Treatment Outcome | 2011 |
A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
Topics: Animals; Bupropion; Callithrix; Dose-Response Relationship, Drug; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Stereoisomerism | 2011 |
Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.
Topics: Adrenergic Agents; Animals; Antidepressive Agents; Antiparkinson Agents; Behavior, Animal; Bupropion; Disease Models, Animal; Immunohistochemistry; Levodopa; Mood Disorders; Motor Activity; Oxidopamine; Parkinsonian Disorders; Paroxetine; Rats; Rats, Wistar | 2013 |